Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07120191 · ClinicalTrials.gov registry record
An Open Label Data Collection Study of My Connect Post-Op, a Post-Operative Communication Tool
A clinical trial of Total Knee Replacement and Total Hip Replacement, sponsored by Concentra AI.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT07120191: Recruiting study of Total Knee Replacement and Total Hip Replacement, sponsored by Concentra AI.
NCT07120191 is a study of Total Knee Replacement and Total Hip Replacement that is actively recruiting participants, run by Concentra AI. The registered enrollment target is 200 participants, roughly in line with the 194-participant average among 9 other Total Knee Replacement trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07120191, a study of Total Knee Replacement and Total Hip Replacement, is actively recruiting participants, sponsored by Concentra AI.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This open label, multi-center study will collect data from the participant's use of My Connect Post-Op Software as a post-operative communication solution in supporting patient recovery through Technology-Assisted Conversation (TAC). The application will be tested by patients who have undergone total joint replacement as a post-op communication tool. Data will be collected on how effectively the product guides patients through their recovery, identifying potential complications, and providing appropriate recommendations based on structured question pairs.
Primary Outcome
Collect conversations between the participant and the clinically conversant AI
Conditions Studied
Interventions
- DEVICE post op communication software
Study Locations (1)
Kansas
- Kansas Joint and Spine - Wichita
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2025-11-30 |
What NCT07120191 shows while recruiting
NCT07120191 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 194-participant average among 9 other Total Knee Replacement trials with a reported enrollment target.
The record links to 2 conditions, with Total Knee Replacement appearing as the primary indexed condition, and to 1 intervention - of which post op communication software is the first listed.
NCT07120191 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT07120191 about?
NCT07120191 is a clinical study titled "An Open Label Data Collection Study of My Connect Post-Op, a Post-Operative Communication Tool". This open label, multi-center study will collect data from the participant's use of My Connect Post-Op Software as a post-operative communication solution in supporting patient recovery through Technology-Assisted Conversation (TAC). The application will be tested by patients who have undergone tota...
What is the current status of trial NCT07120191?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2025-05-01. Estimated completion is 2025-11-30.
What conditions does trial NCT07120191 study?
This clinical trial studies the following conditions: Total Knee Replacement, Total Hip Replacement.
What interventions are being tested in trial NCT07120191?
The interventions under investigation include: post op communication software (DEVICE).
Who is sponsoring clinical trial NCT07120191?
This trial is sponsored by Concentra AI, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07120191 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Total Knee Replacement
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07120191's enrollment target sits among peer trials
200 4th of 9 higher than 6 of 9 other Total Knee Replacement trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Total Knee Replacement trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Yale Steroid Enhanced Versus Exparel Nerveblock TKA RCT Study
RECRUITING · Phase 2
-
Yale Steroid Enhanced Versus Exparel Nerveblock TKA Part 2
RECRUITING · Phase 2
-
Adductor Canal Block
ACTIVE NOT RECRUITING · Phase 2
-
Knee Arthroplasty Activity Trial
ACTIVE NOT RECRUITING · NA
-
Metal Ion Concentrations After Total Knee Arthroplasty
ACTIVE NOT RECRUITING
-
Antibiotic Elution in Total Knee Arthroplasty
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI